Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-054136

Director acquired 45,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GREER R SCOTT Director 2021-08-31 Option exercise +45,000 $12.70 $571,500 270,674 D
Derivatives
GREER R SCOTT Director 2021-08-31 Option exercise · Stock Option −45,000 0 D
Loading xslF345X03/doc4.xml…